Overview
Aemetis Q2 revenue of $52.2 mln missed analyst expectations, per LSEG data
Net loss improved to $23.4 mln but missed analyst estimates, per LSEG data
Operating loss improved to $10.7 mln, still missed analyst expectations, per LSEG data
Outlook
Aemetis expects increased revenues from new dairy digester RNG pathways
Company anticipates higher operating cash flow from vapor recompression project
Aemetis India subsidiary targets public listing in early 2026
Company sees revenue boost from extended federal tax credits
Result Drivers
INDIA BIODIESEL - Revenue increase driven by restart of biodiesel deliveries under new orders from Oil Marketing Companies
BIOGAS REVENUE - Aemetis Biogas recognized $3.1 mln in revenue from 11 digesters, aided by new LCFS pathways approved by CARB
SG&A REDUCTION - Operating loss improved by $4.9 mln due to reduced SG&A expenses in Q2 2025
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $52.24 mln | $82.90 mln (5 Analysts) |
Q2 Net Income | Miss | -$23.40 mln | -$18.10 mln (5 Analysts) |
Q2 Operating Income | Miss | -$10.67 mln | -$2.79 mln (5 Analysts) |
Q2 Pretax Profit | Miss | -$23.92 mln | -$17.60 mln (5 Analysts) |
Press Release: ID:nGNXccbLpW